XML 164 R23.htm IDEA: XBRL DOCUMENT
v3.26.1

Concentration and risk | 9 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2026 | Jun. 30, 2025
Exascale Labs Inc. [Member] |  |
Concentration and risk | 3. Concentration and risk Concentration of credit risk Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company performs ongoing credit evaluations of the customers’ financial condition and maintains an allowance for potential credit losses. This allowance consists of an amount identified for specific customers and an amount based on overall estimated exposure. Our overall estimated exposure excludes amounts covered by credit insurance. Concentration of customers The Company’s revenue was concentrated among a limited number of customers during the periods presented. The following table summarized customers with greater than 10% of the total revenue:
Schedule of Concentration of customers |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | For the Three Months Ended March 31, |  |  | For the Nine Months Ended March 31, |
|  | 2025 |  |  | 2026 |  |  | 2025 |  |  | 2026 |
Customer A |  |  | -** |  |  |  | 24.9 | % |  |  | -** |  |  |  | 24.6 | %
Customer B |  |  | 11.7 | % |  |  | 11.8 | % |  |  | 10.0 | % |  |  | 22.3 | %
Customer C |  |  | 13.7 | % |  |  | -** |  |  |  | 17.0 | % |  |  | -** |
Customer D |  |  | -** |  |  |  | -** |  |  |  | 10.2 | % |  |  | -** |
Customer E |  |  | -** |  |  |  | -** |  |  |  | 10.1 | % |  |  | -** |
Customer F |  |  | 15.6 | % |  |  | -** |  |  |  | -** |  |  |  | -** |
**: | less than 10%
The Company’s account receivable was concentrated among a limited number of customers during the periods presented. The following table summarized customers with greater than 10% of the total account receivable:
Schedule of account receivable |  |  |  |  |  |  |  |
|  | As of June 30, |  |  | As of March 31, |
|  | 2025 |  |  | 2026 |
Customer A |  |  | -** |  |  |  | 29.7 | %
Customer B |  |  | -** |  |  |  | 19.5 | %
Customer E |  |  | -** |  |  |  | 10.5 | %
Customer G |  |  | 42.7 | % |  |  | -** |
Customer H |  |  | 38.3 | % |  |  | -** |
Customer I |  |  | 19.0 | % |  |  | -** |
**: | less than 10%
Concentration of suppliers The Company’s purchases was concentrated among a limited number of suppliers during the periods presented. The following table summarized suppliers with greater than 10% of the total purchase:
Schedule of Concentration of suppliers |  |  |  |  |  |
|  | For the Three Months Ended March 31, |  |  | For the Nine Months Ended March 31, |
|  | 2025 |  |  | 2026 |  |  | 2025 |  |  | 2026 |
Supplier A |  |  | -* |  |  |  | 13.0 | % |  |  | -* |  |  |  | 26.4 | %
Supplier B |  |  | 14.4 | % |  |  | 30.2 | % |  |  | 21.1 | % |  |  | 24.9 | %
Supplier C |  |  | 32.9 | % |  |  | 33.7 | % |  |  | 24.0 | % |  |  | 24.2 | %
Supplier D |  |  | -* |  |  |  | 13.8 | % |  |  | -* |  |  |  | 11.5 | %
Supplier E |  |  | 45.5 | % |  |  | -** |  |  |  | 47.6 | % |  |  | -** |
*: | nil, new supplier for the nine months ended March 31, 2026
**: | less than 10%
The Company’s account payable was concentrated among a limited number of suppliers during the periods presented. The following table summarized suppliers with greater than 10% of the total account payable:
Schedule of account payable |  |  |  |  |  |
|  | As of June 30, |  |  | As of March 31, |
|  | 2025 |  |  | 2026 |
Supplier B |  |  | 12.1 | % |  |  | 74.0 | %
Supplier D |  |  | -* |  |  |  | 12.6 | %
Supplier E |  |  | -** |  |  |  | 13.4 | %
Supplier F |  |  | 54.9 | % |  |  | -** |
Supplier G |  |  | 32.3 | % |  |  | -** |
*: | nil, new supplier for the nine months ended March 31, 2026
**: | less than 10%
| 3. Concentration and risk Concentration of credit risk Financial instruments that potentially subject us to concentrations of credit risk consisted primarily of cash and cash equivalents, and accounts receivable. We perform ongoing credit evaluations of our customers’ financial condition and maintain an allowance for potential credit losses. This allowance consisted of an amount identified for specific customers and an amount based on overall estimated exposure. Our overall estimated exposure excludes amounts covered by credit insurance. Concentration of customers The Company’s revenue was concentrated among a limited number of customers during the periods presented. The following table summarized customers with greater than 10% of the total revenue:
Schedule of Concentration of customers |  |  |  |  |  |  |  |
|  | For the years ended June 30, |
|  | 2024 |  |  | 2025 |
Customer A |  |  | 12.0 | % |  |  | 14.0 | %
Customer B |  |  | -* |  |  |  | 12.5 | %
Customer C |  |  | -* |  |  |  | 10.2 | %
Customer D |  |  | 31.6 | % |  |  | -** |
Customer E |  |  | 11.9 | % |  |  | -** |
Customer F |  |  | 11.0 | % |  |  | -** |
| *: | nil, new customer for the year ended June 30, 2025
| **: | less than 10%
The Company’s account receivable was concentrated among a limited number of customers during the periods presented. The following table summarized customers with greater than 10% of the total account receivable:
Schedule of account receivable |  |  |  |  |  |  |  |
|  | As of June 30, |
|  | 2024 |  |  | 2025 |
Customer G |  |  | -* |  |  |  | 42.7 | %
Customer H |  |  | -* |  |  |  | 38.3 | %
Customer F |  |  | 23.4 | % |  |  | 19.0 | %
Customer D |  |  | 43.5 | % |  |  | -** |
Customer I |  |  | 15.3 | % |  |  | ** |
| *: | nil, new customer for as of June 30, 2025
| **: | less than 10%
Concentration of suppliers The Company’s purchases was concentrated among a limited number of suppliers during the periods presented. The following table summarized suppliers with greater than 10% of the total purchase:
Schedule of Concentration of suppliers |  |  |  |  |  |  |  |
|  | For the years ended June 30, |
|  | 2024 |  |  | 2025 |
Supplier A |  |  | 56.6 | % |  |  | 41.4 | %
Supplier B |  |  | 14.6 | % |  |  | 31.7 | %
Supplier C |  |  | -** |  |  |  | 18.4 | %
Supplier D |  |  | 12.8 | % |  |  | -** |
| **: | less than 10%
The Company’s account payable was concentrated among a limited number of suppliers during the periods presented. The following table summarized suppliers with greater than 10% of the total account payable:
Schedule of account payable |  |  |  |  |  |  |  |
|  | As of June 30, |
|  | 2024 |  |  | 2025 |
Supplier E |  |  | -* |  |  |  | 54.9 | %
Supplier F |  |  | -* |  |  |  | 32.3 | %
Supplier C |  |  | 99.4 | % |  |  | 12.1 | %
| *: | nil, new supplier for the year ended June 30, 2025

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (d)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (d)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 3A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482836/275-10-55-3A Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-2A Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1 Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/275/tableOfContent + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=cik0002065779_ExascaleLabsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |